(Q35179552)

7 August 2017

0 references

1 reference

title

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension (English)

1 reference

7 August 2017

0 references

1 reference

4

Franz H Messerli

1 reference

7 August 2017

5

Roland E Schmieder

1 reference

7 August 2017

Arnfried U Klingbeil

1

1 reference

7 August 2017

Markus Schneider

series ordinal

2

1 reference

7 August 2017

Peter Martus

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

115

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

41-46

1 reference

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Prognostic significance of serial changes in left ventricular mass in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Left ventricular mass change during treatment and outcome in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Reduction of left ventricular mass by antihypertensive treatment does not improve exercise performance in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Different effects of fosinopril and atenolol on wave reflections in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effect of treatment of isolated systolic hypertension on left ventricular mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

A Comparison of the Effects of Mibefradil and Atenolol on Regression of Left Ventricular Hypertrophy in Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Changes in arterial structure and function under trandolapril-verapamil combination in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischaemia in elderly patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effects of losartan on hypertension and left ventricular mass: a long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Hydrochlorothiazide Is Superior to Isradipine for Reduction of Left Ventricular Mass: Results of a Multicenter Trial fn1fn1This study was supported by an unrestricted grant from Sandoz Pharmaceuticals, East Hanover, New Jersey.fn2fn2To discuss this a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Physical performance is preserved after regression of left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Comparison of Spirapril, Isradipine, or Combination in Hypertensive Patients With Left Ventricular Hypertrophy Effects on LVH Regression and Arrhythmogenic Propensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

One-year study of felodipine or placebo for stage 1 isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Reversal of pathophysiologic changes with long-term lisinopril treatment in isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

The effects of modulation of calcium influx through the voltage-sensitive calcium channel on cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900158-X

10.1016/S0002-9343(03)00158-X

7 January 2021

Identifiers

DOI

1 reference

7 August 2017

1 reference